PRECIOUS SARVER: Open Payments
NPI 1972238467 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 24 payments from 6 companies in 2025. Trend: 2023 $827 · 2024 $1,007 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $140 |
| Vanda Pharmaceuticals Inc. | 9 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $85 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| Lundbeck LLC | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, HETLIOZ, CAPLYTA, Auvelity, REXULTI, FANAPT, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
